ES2180407A1 - Produccion en la levadura pichia pastoris, y sistema de aislamiento y purificacion, del alergeno recombinante de olea europea ole e 9 para uso en diagnosis y tratamiento de alergias. - Google Patents

Produccion en la levadura pichia pastoris, y sistema de aislamiento y purificacion, del alergeno recombinante de olea europea ole e 9 para uso en diagnosis y tratamiento de alergias.

Info

Publication number
ES2180407A1
ES2180407A1 ES200100302A ES200100302A ES2180407A1 ES 2180407 A1 ES2180407 A1 ES 2180407A1 ES 200100302 A ES200100302 A ES 200100302A ES 200100302 A ES200100302 A ES 200100302A ES 2180407 A1 ES2180407 A1 ES 2180407A1
Authority
ES
Spain
Prior art keywords
allergen
ole
olea europaea
proteins
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200100302A
Other languages
English (en)
Other versions
ES2180407B1 (es
Inventor
Garcia Rosalia Rodriguez
Diaz M Teresa Villalba
Clemente Rafael Mosalve
Cremades Eva Batanero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Complutense de Madrid
Original Assignee
Universidad Complutense de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Complutense de Madrid filed Critical Universidad Complutense de Madrid
Priority to ES200100302A priority Critical patent/ES2180407B1/es
Priority to PCT/ES2002/000060 priority patent/WO2002070716A1/es
Publication of ES2180407A1 publication Critical patent/ES2180407A1/es
Application granted granted Critical
Publication of ES2180407B1 publication Critical patent/ES2180407B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Pulmonology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Producción en la levadura Pichia pastoris, y sistema de aislamiento y purificación, del alergeno recombinante de Olea europaea Ole e 9 para uso en diagnosis y tratamiento de alergias. Se ha clonado y expresado el DNA recombinante que codifica el alergeno Ole e 9 de polen de olivo (Olea europaea). Este alergeno tiene actividad b-1,3-glucanasa y presenta una alta homología con estas proteínas. Se han detectado también proteínas homólogas a este alergeno en otros pólenes como el de otras miembros de la familia de las Oleaceas (Syringa vulgaris, Ligustrum vulgare y Fraxinus excelsior). La proteína recombinante producida en la levadura (Pichia pastoris) se aísla con gran rendimiento, está correctamente plegada y exhibe propiedades inmunológicas equivalentes a las del alergeno natural por lo que tanto ella como las proteínas homólogas, las formas modificadas derivadas de ellas, los fragmentos derivados que contengan al menos un epítopo alergénico, pueden ser empleadas en protocolos de diagnosis einmunoterapia.
ES200100302A 2001-02-09 2001-02-09 Produccion en la levadura pichia pastoris, y sistema de aislamiento y purificacion, del alergeno recombinante de olea europea ole e 9 para uso en diagnosis y tratamiento de alergias. Expired - Fee Related ES2180407B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES200100302A ES2180407B1 (es) 2001-02-09 2001-02-09 Produccion en la levadura pichia pastoris, y sistema de aislamiento y purificacion, del alergeno recombinante de olea europea ole e 9 para uso en diagnosis y tratamiento de alergias.
PCT/ES2002/000060 WO2002070716A1 (es) 2001-02-09 2002-02-08 Producción en la levadura pichia pastoris, y sistema de aislamiento y purificación, del alergeno recombianante de olea europaea ole e 9 para uso en diagnosis y tratamiento de alergias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200100302A ES2180407B1 (es) 2001-02-09 2001-02-09 Produccion en la levadura pichia pastoris, y sistema de aislamiento y purificacion, del alergeno recombinante de olea europea ole e 9 para uso en diagnosis y tratamiento de alergias.

Publications (2)

Publication Number Publication Date
ES2180407A1 true ES2180407A1 (es) 2003-02-01
ES2180407B1 ES2180407B1 (es) 2004-07-01

Family

ID=8496687

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200100302A Expired - Fee Related ES2180407B1 (es) 2001-02-09 2001-02-09 Produccion en la levadura pichia pastoris, y sistema de aislamiento y purificacion, del alergeno recombinante de olea europea ole e 9 para uso en diagnosis y tratamiento de alergias.

Country Status (2)

Country Link
ES (1) ES2180407B1 (es)
WO (1) WO2002070716A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2255340A1 (es) * 2003-02-04 2006-06-16 Universidad Complutense De Madrid Produccion, sistema de aislamiento y purificacion del alergeno ole e 10.

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4730764B2 (ja) * 2005-02-14 2011-07-20 国立大学法人広島大学 スギ花粉由来の新規アレルゲン
ES2315076B1 (es) * 2006-02-09 2009-11-23 Asac Compañia Biotecnologia E Investigacion Sa Hospedador transformado para la produccion de alergenos.

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BATANERO, E. et al. "Isolation and characterization of an olive allergen-like protein from lilac pollen". EUR. J. BIOCHEM., Vol. 221, 1994, pßginas 187-193, todo el documento. *
BATANERO, E. et al. "Isolation, cDNA cloning and expression of Lig v 1, the mayor allergen from privet pollen". CLINICAL AND EXPERIMENTAL ALLERGY, Vol. 26, 1996, pßginas 1401-1410, todo el documento. *
HUECAS, S. et al. "Production and detailed characterization of biologically active olive pollen allergen Ole e 1 secreted by the yeast Pichia pastoris". EUR. J. BIOCHEM., Vol. 261, abril 1999, pßginas 539-545, todo el documento. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2255340A1 (es) * 2003-02-04 2006-06-16 Universidad Complutense De Madrid Produccion, sistema de aislamiento y purificacion del alergeno ole e 10.

Also Published As

Publication number Publication date
ES2180407B1 (es) 2004-07-01
WO2002070716A1 (es) 2002-09-12

Similar Documents

Publication Publication Date Title
Hoffman Hymenoptera venom allergens
WO2003018771A3 (en) A system for antibody expression and assembly
HK1061566A1 (en) Proteins producing an altered immunogenic response and methods of making and using the same
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
WO2005087261A3 (en) Identification of self and non-self antigens implicated in autoimmune diseases
WO2004013287A3 (en) Antibodies against c3a receptor
WO2003033658A3 (en) Neutrokine-alpha and neutrokine-alpha splice variant
WO2003102136A3 (en) Antibodies that specifically bind to neurokinin b
ES2180407A1 (es) Produccion en la levadura pichia pastoris, y sistema de aislamiento y purificacion, del alergeno recombinante de olea europea ole e 9 para uso en diagnosis y tratamiento de alergias.
PL335981A1 (en) Modified recombinative alegenes of gramminae pollen for use in specific immunotherapy, method of obtaining them and their application
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
Ferreira et al. Isoforms of atopic allergens with reduced allergenicity but conserved T cell antigenicity: possible use for specific immunotherapy
WO2002012503A8 (es) Producción en la levadura pichia pastoris y sistema de purificación del alergeno recombinante de olea europaea olee 1 para uso en diagnosis y tratamiento de alergias
WO2015070925A1 (en) Fusion proteins
DE60125528D1 (de) Isolierung und charakterisierung des csa-operons (etec-cs4 pili) und verfahren zu dessen anwendung
WO2002028889A3 (en) Haemophilus influenzae antigens and corresponding dna fragments
PL340293A1 (en) Tolerance producing fragments of natural allergens
WO2002099062A3 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
AU776154B2 (en) Method for isolating and purifying grass pollen allergens
AU2001292230A1 (en) Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them
WO2005058936A3 (de) Dna-sequenz und rekombinante herstellung des graspollen-allergens lol p 4
WO2002090504A3 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
WO2004031354A3 (en) Human sarcoma-associated antigens
SI1351988T1 (sl) IgG-molekule, specifične za alergene skupine 2, in njihova uporaba

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030201

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2180407B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20210526